Navigation Links
Despite New Changes, Highmark Policy Still Threatens Patients With Primary Immunodeficiency Diseases
Date:3/21/2011

HARRISBURG, Pa., March 21, 2011 /PRNewswire/ -- Beginning April 1, Highmark Blue Cross Blue Shield (Highmark) will force a number of their insured patients with primary immunodeficiency diseases and other rare disorders to switch their prescription to a single brand of immunoglobulin (IgG - a blood plasma product), regardless of their current IgG therapy. Under the new Highmark "formulary," even patients who are being treated successfully with another brand of IgG will have to "fail first" on the new treatment, before being allowed to switch back to their original product. In other words, patients must become ill and suffer possible life-threatening reactions before Highmark will even consider covering another IgG product for that patient.

"Immediately after our public protest last week of this unconscionable intrusion into the patient and physician relationship, Highmark responded with some proposed modifications," stated Dr. Michael Blaese, Consulting Medical Director of the Immune Deficiency Foundation (IDF). "But they still fail to address the fundamental issue at hand - instead of doctors who are experienced in treating primary immunodeficiency diseases, Highmark will be making the determination about which IgG therapy will be the most appropriate for patients."

IgG therapy is a biological treatment that, unlike most prescription drugs, is not generic or interchangeable. While all IgG products are FDA approved therapies for patients with primary immunodeficiency diseases, the FDA recognizes each as a unique therapy as a result of the manufacturing processes, stabilizers used, and other factors that make each product different.  In fact, patients can experience a wide range of adverse reactions to one IgG product while tolerating others without problems. Medical literature indicates that up to 34% of patients who switch from one IgG product to another will suffer adverse reactions, including severe and life-threatening reacti
'/>"/>

SOURCE Immune Deficiency Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Women Get Short Shrift in Many Heart Device Studies, Despite Requirement
2. Report: Inappropriate Antibiotic Use Still High Despite Educational Efforts
3. Parents Continue to Give Cough and Cold Meds to Young Kids, Despite FDA Warnings
4. An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety
5. Half of All Women Do Not Get Regular Mammograms Despite Recommended Guidelines
6. Reportlinker Adds Russia Pharmaceutical Market Overview Pharma Companies Target Russia Despite the Challenges it Presents
7. Despite Rising Procedure Volumes, the $30 Million European Arthroscope Market Experienced Nominal Growth in 2010
8. NCPA Digest Finds Independent Community Pharmacies Stable Despite Economic, Third-Party Challenges
9. Despite Potential Risk of Serious Birth Defects, New Study Finds Poor Adherence to Oral Contraception among Women on Category X Medications
10. Despite Dramatic Changes, the Crohns Disease Drug Market Will Experience Only Moderate Growth Through 2019
11. Study of Brands Shows Tylenol Maintains Consumer Loyalty Despite Recent Quality Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... N.C. , April 17, 2015  Healthcare ... creation of many new forms of provider networks, ... Care Organizations (ACOs). The rapid evolution of these ... adapt their access, pricing and service delivery systems ... To help the pharma sector adapt ...
(Date:4/17/2015)... Inivata, a Cambridge, England ... presence at the 2015 American Association for Cancer Research (AACR) ... Nitzan Rosenfeld and a poster presentation. Michael Stocum ... - 22 nd . The presentation, entitled ... forms part of a session on Recent Advances ...
(Date:4/17/2015)... 17, 2015 Research and Markets ( ... "ADME-Toxicology Testing - Global Strategic Business Report" report ... worldwide markets for ADME-Toxicology Testing in US$ Million by ... ADME Testing. The report provides separate comprehensive ... Japan , Europe ...
Breaking Medicine Technology:Pharmaceutical Industry Struggling to Better Serve Provider Networks Such as Accountable Care Organizations (ACOs) 2Inivata Co-founder Nitzan Rosenfeld to Present at AACR Annual Meeting 2ADME-Toxicology Testing (In-Vivo, & In-Vitro) Market - Global Strategic Business Report 2015: Pharma Industry Renews Focus on Cost Optimization 2
... April 4, 2011 Morphotek®, Inc., a subsidiary ... acquired certain assets relating to a proprietary tumor ... undisclosed upfront payment and future development milestones. TMI, ... PA, developed the tumor-targeting peptide (TTP) platform capable ...
... 2011 PLC Systems Inc. (OTCBB: PLCSF), a ... that final results from the REMEDIAL II investigator-sponsored ... today. The results showed that RenalGuard was much ... at preventing Contrast-Induced Nephropathy (CIN) and Dialysis in ...
Cached Medicine Technology:Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc. 2Morphotek®, Inc. Announces Acquisition of Tumor Targeting Assets From Transmolecular, Inc. 3REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care 2REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care 3REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care 4
(Date:4/17/2015)... (PRWEB) April 17, 2015 In Defense ... the following statement: “On Wednesday April 15th, the European ... adopted a resolution recognizing the Armenian Genocide, “paying tribute, ... of the one-and-a-half million innocent Armenian victims who perished ... (IDC) extols the EU for this timely and needed ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 As a ... in his new offering of platelet-rich plasma (PRP) ... Medicine (MOSM) is known for its world-class care ... brings extensive surgical experience lacking in many other physicians ... cell treatments are utilized for pain management and rehabilitation. ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Baptist Health ... have signed a partnership agreement designed to transform oncology ... The institutions have agreed to create a joint cancer ... protocols and translational research. Baptist MD Anderson Cancer Center ... providing a single destination for highly coordinated, multidisciplinary cancer ...
(Date:4/17/2015)... Connie Casad, M.D., a well-known and respected gynecologist, ... years of practice experience in Dallas, Texas, has announced ... for her patients with the availability of a reader’s ... with a brief synopsis on each for her patients. ... providing this service, Dr. Casad said, “Furnishing a researched ...
(Date:4/17/2015)... Jersey City, NJ (PRWEB) April 17, 2015 ... is stored in the posterior pituitary and thought to ... strengthening bonding between couples. To further substantiate this, new ... published in the journal, Nature, and reported by Medical ... does have a powerful influence over maternal social behavior. ...
Breaking Medicine News(10 mins):Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 2Health News:Platelet-Rich Plasma, Stem Cell Therapy Now Offered By Dr. Meier At MOSM in Beverly Hills, California 3Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3
... , Jan. 15 Representatives from the ... organizations, attended the first consortium meeting aimed at developing ... lupus diagnosis, treatment, and management among minorities. The meeting, ... Atlanta, Georgia from January 12–14, 2010, was ...
... , YONKERS, N.Y. , Jan. 15 ... expressed disappointment with the U.S. Food & Drug Administration,s (FDA) ... today that there is cause for concern over its potential ... enough scientific evidence to date to warrant a ban on ...
... PHOENIX , Jan. 15 NutraCea (OTC: ... and technology, today announced a 17% reduction in its U.S. workforce ... structure. The reduction, which is anticipated to save NutraCea approximately ... NutraCea,s Brazilian subsidiary. , W. John Short , Chairman & ...
... , American Humane First to Join ... 15 The American Humane Association is part ... international group of professional animal welfare organizations committed to aiding animals ... join and commit significant resources to ARCH, which was created by ...
... NJ , Jan. 15 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals ... be distributing to shareholders an additional supplement (the "Supplement") to ... previously delivered to shareholders in connection with the Special ... 2009 . The special meeting was originally held to consider ...
... WESTPORT, Conn. , Jan. 15 The devastating, ... a dire living situation, particularly for those Haitians living with ... to specific segments of the population, such as those victims ... dLife, which has the largest online diabetes community, aims to ...
Cached Medicine News:Health News:Lupus Foundation of America Collaborates with Federal Agencies and the U.S. Surgeon General's Office to Expand Medical Education on Lupus 2Health News:Lupus Foundation of America Collaborates with Federal Agencies and the U.S. Surgeon General's Office to Expand Medical Education on Lupus 3Health News:Consumers Union Disappointed with FDA's Action on BPA, Despite Admission of 'Some Concern' 2Health News:Consumers Union Disappointed with FDA's Action on BPA, Despite Admission of 'Some Concern' 3Health News:NutraCea Announces Reduction in Workforce in U.S. Operations 2Health News:American Humane Association Supports Animal Relief Efforts in Haiti Through International Coalition 2Health News:American Humane Association Supports Animal Relief Efforts in Haiti Through International Coalition 3Health News:NUCRYST Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders 2Health News:NUCRYST Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders 3Health News:NUCRYST Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders 4Health News:dLife Connects Largest Online Diabetes Community to Facilitate Aid to Haitian Earthquake Victims Suffering From Diabetes 2
... a low-profile, wraparound, hinged knee product with ... patients who have difficulty applying a sleeve, ... for ease of application. These pull ... easily secure the anterior closure of the ...
... might just be the world's most versatile ... support, post-op/rehab support, or both, Flex is ... Accutrac™ ROM hinges control flexion and extension ... durability while being heat-moldable to accommodate changes ...
... CartiCare enables unloading of the medial or ... with unicompartmental osteoarthritis. Plus, we equipped this ... hinge, making it further suitable for post-op ... and/or adjustable flexion/extension control. , ,Indications: ...
... of the Custom Montana2 alleviates the ... three-point load across the knee joint, ... area. The Diagonal Loading Strap gives ... the load to accommodate their daily ...
Medicine Products: